Medical Device Product Development: The 5 Phases, From Concept to Market

Written By Caroline

Published on September 30, 2026

Last Edit on October 06, 2026

Medical device product development runs across five phases, and each one closes on concrete deliverables: user needs, design inputs, design outputs, verification and validation evidence, and a design package ready for manufacturing transfer.

This guide covers everything from concept to market: what happens in each phase, what it costs in time, which standards apply, and where schedules usually slip.

What Is Medical Device Product Development?

Medical device product development is the regulated path that takes a clinical need through research, design, engineering, verification, validation and manufacturing transfer, until the device can be legally marketed.
What sets it apart from other kinds of product development is the paper trail: every decision has to be documented, traceable and defensible to a regulator, because patient safety depends on it.
That documentation sounds heavy, and some weeks it is. It’s also what makes the medical device industry different: on top of the engineering, you’re working through complex regulations, clinical data and a regulator who reviews your records. But that same discipline is what lets you show, two years into a program, exactly why a button sits where it does and which patient need it answers.

Regulatory compliance is part of every phase, from the first site visit to the last production lot.

What Is the Difference Between Medical Device Design and Development?

The two words describe different work, but under a quality management system they are governed as one controlled process with shared documentation.

Design covers what the device does and how a clinician or patient interacts with it: the intended use, the interface, the form factor, the workflow it has to fit into. Development covers how the device is actually built and proven: architecture, components, code, tolerances, testing, manufacturing readiness.

Medical device design and development is treated as a single regulated activity under ISO 13485 and FDA 21 CFR Part 820, which govern design controls from design inputs through design transfer. Splitting the two in practice is where traceability breaks down, because a design change made without a corresponding development record leaves a gap a regulator will find.

Which Standards and Regulations Apply?

In the US, the backbone is FDA’s Quality Management System Regulation (QMSR). Since February 2, 2026, 21 CFR Part 820 incorporates ISO 13485:2016 by reference, and compliance with it is a regulatory requirement for manufacturers selling in the US.

In Canada, Health Canada’s Medical Devices Regulations sort devices into four risk classes, from Class I (lowest risk) to Class IV (highest). Class II, III and IV devices need a medical device licence before they can be sold, and the application requires an ISO 13485 certificate issued under the Medical Device Single Audit Program (MDSAP). Class I devices don’t need a licence, but they’re monitored through establishment licensing.

In plain terms, the same quality management system standard now applies on both sides of the border. MDSAP helps here too: FDA and Health Canada both take part in the program, and FDA can accept an MDSAP audit report in place of a routine inspection.

Around ISO 13485, a handful of standards come up on most programs in the medical device industry:
StandardWhat it covers
ISO 14971Risk management across the whole device lifecycle
IEC 62366-1Usability engineering
IEC 62304The software lifecycle
IEC 60601-1Basic safety and essential performance of medical electrical equipment
ISO 10993-1Biological evaluation of materials that contact the body

The standards in the table appear on both FDA’s and Health Canada’s lists of recognized standards. Following them makes compliance far easier to demonstrate in your submission.

“The application of recognized standards is voluntary, not compulsory. However, adherence to these internationally recognized methods facilitates the review for market authorization applications. Simply refer to the lists of recognized standards in the guides and databases provided by each jurisdiction.”

Caroline Lau
Quality Assurance Coordinator at CLEIO

What Are the 5 Key Phases of Medical Device Product Development?

At CLEIO, we run every medical device program through five phases we call IDEAL: Immerse, Define, Elaborate, Adapt and Launch. Together, the five phases cover the design process regulators expect, from user needs and design inputs to verification, validation and design transfer.

One thing to keep in mind before we go through them one by one: the process is iterative. Design, engineering, testing and risk management keep informing one another, so expect to revisit earlier decisions as you learn.

Immerse

Understand the problem and the market

Define

Define the solution

Elaborate

Build the solution

Adapt

Test & certify the solution

Launch

Bring the solution to market
The 5 phases of medical device product development: Immerse, Define, Elaborate, Adapt and Launch

1

Immerse: Understand the Clinical Need and Check Feasibility

Immerse is the first step: it’s where you figure out what problem you’re actually solving, for whom, and in what setting. That means user research, observing clinical workflows alongside healthcare professionals, market research on existing solutions and your first round of regulatory homework.

It’s also where you take a first look at technical feasibility: can the concept you have in mind be built, powered, cleaned and manufactured at a cost the market will accept?
It’s tempting to rush this stage. Resist it. The real use environment has a way of overturning assumptions that looked solid in a conference room.
Lighting, noise, available space, gloves, cleaning routines, the age of your patients: any one of them can change the interface you thought you needed. Finding that out now costs a few site visits. Finding it out after the design phase costs a redesign.
What comes out of Immerse: a clear description of who will use the device, where, and what they need, plus an initial concept worth pursuing. Everything downstream traces back to it.
“When developing medical products, the context of use is the guiding principle that should inform every stage of the process. A client may insist that their device be the quietest on the market, but without understanding where and how it will be used, this requirement could fade into an insignificant whisper.”

François Gélinas
Director of Design at CLEIO

2

Define: Turn Research Into Requirements and a Risk Analysis

Define translates what you learned into something engineers can build against and testers can verify: design inputs. Functional requirements, performance requirements, safety requirements, interface behavior, technical constraints and the intended use statement all land here.

This is also where risk management starts. An initial risk analysis identifies hazards and estimates risks while the design is still cheap to change, and the risk controls you choose become requirements too.

And it’s where you answer the regulatory question: what class is your device, and which pathway will it take to market? That answer sets the regulatory requirements you’ll have to meet, and with them your development plan, your compliance documentation and your timeline. If you’re unsure, we break it down in our guide on how to identify the regulatory pathway for your medical device.

3

Elaborate: Develop the Concept Through Prototyping

Elaborate is where the concept becomes a real device. Industrial designers and mechanical, electronic and embedded engineers work in parallel, and medical device prototyping takes you from rough proofs of concept to fully functional prototypes. Proofs of concept are where technical feasibility gets confirmed or ruled out, cheaply.

Two habits make this phase go well. First, run formative evaluations early, alongside prototyping: small usability studies that show you where people struggle while you can still change the design. Second, hold design reviews at every design stage, and make sure they actually look for problems while changes are still manageable.
Reviews are where the small details get caught: a connector that can be installed backwards, a label that’s hard to read under real lighting, a tolerance stack that only works on a hand-built prototype. Each one is cheap to fix on paper and expensive to fix in production.
By the end of Elaborate, you have design outputs: drawings, design specifications, a bill of materials, code. The next phase will check each of them against the design inputs from Define.

4

Adapt: Verification and Validation

In Adapt, you test the device to show that it meets its safety and performance requirements. These tests produce most of the evidence regulators will review. Two activities matter a lot here. Verification asks whether you built the device according to its specifications. Validation asks whether you built the right device for its intended use and the people who rely on it.

Verification covers bench testing against each design input, electrical safety and performance testing under IEC 60601-1 for powered devices, and biocompatibility evaluation for materials that contact the body. If your device runs code, that software follows its own lifecycle under IEC 62304, and its verification records feed the same design history file as the hardware. We cover the requirements, safety classes and development steps in our guide to medical device software development.

Validation includes human factors validation testing, also called summative evaluation, built on IEC 62366-1 usability engineering. It’s run on the final design, and FDA’s human factors guidance calls for at least 15 participants from each distinct user population. So if your device is used by both healthcare professionals and patients at home, plan for two groups of at least 15.

Clinical data comes in here too, when your pathway requires it. For a PMA, that generally means clinical trials designed to show the device is safe and effective for its intended use.

5

Launch: Transfer to Manufacturing and Go to Market

Launch is the handoff from development to production. Design transfer makes sure your manufacturing processes reproduce the final, validated design, unit after unit, lot after lot. Before full-scale production begins, you’ll validate the manufacturing process, qualify your suppliers and double-check every label.

Your regulatory submission goes out in this phase too, unless your device is exempt. And once you have clearance or approval, compliance keeps going: you’ll handle complaints, keep an eye on the device’s real-world performance, update your risk analysis regularly and feed everything you learn back into the design.

Case Study

Discover our case study on how we designed SoundBite's Medical Console

How Long Does Medical Device Product Development Take?

Three factors drive the timeline, as do the budget: the complexity of your device, its regulatory pathway, and the number of design iterations you go through before the design is stable enough to freeze. Everything else is a matter of planning around those three.
Device classTypical pathwayEvidence requiredDevelopment timeline
Class IMost are exempt from premarket submissionGeneral controls and labeling; design controls apply only to Class I devices with automated software and a short list of named device typesShortest of the three, though quality system and supplier qualification work still apply
Class II510(k)Substantial equivalence to a predicate, bench and usability testing12 to 24 months
Class IIIPMAClinical data, full design history file3 to 5 years
Adding code to a device keeps it on the pathway of its class, with the IEC 62304 lifecycle layered on top. That adds documentation, lifecycle and cybersecurity work to the program rather than a separate regulatory route.

Where Do Timelines Usually Slip?

Three things push a program past its schedule, and all three trace back to a decision made during the first two phases.
  • The regulatory pathway gets confirmed too late

If you classify your device as Class II at kickoff and then have to reclassify it while you prepare the submission, you’ll need a new testing plan and a new documentation scope.

  • Usability problems surface during summative evaluation

If you run your human factors work after you’ve locked the form factor, you have two options: accept a known use error, or reopen tooling.

  • The design history file is assembled after the fact
If you rebuild traceability from finished work instead of building it as you go, you’ll spend more and put your submission date at risk.
“The process starts with rigorous initiation and planning.”

David Dupuis
Director of the Project Management Office at CLEIO

Should You Build In-House or With a Development Partner?

Across the medical device industry, some manufacturers run product development entirely in-house. Others bring in a partner for part of it, or all of it. In practice, the choice comes down to a few questions about your team, your processes and your schedule.

When In-House Development Makes Sense

In-house development works best when you already operate a certified quality management system with the compliance expertise to maintain it, when your team covers human factors, design, engineering and quality without borrowing people from other programs, and when a steady pipeline of device projects keeps that expertise current.

A team that develops one device every four years pays to rebuild the same knowledge each time.

When to Work With a Development Partner

A partner is worth it when your schedule is fixed and your internal team is shared with other priorities, when the program calls for a technical discipline you don’t employ, or when the quality system itself still has to be built. The risk to watch is fragmentation, especially on complex medical devices.
On complex medical devices, choose a partner with an integrated multidisciplinary team. This way, your design documentation stays consistent throughout the program, and you avoid the fragmentation that comes with splitting the work across several specialist vendors.

How CLEIO Handles Medical Device Development

At CLEIO, human factors engineering, industrial design, mechanical and electronic engineering, software and quality work as one team, inside a single ISO 13485 certified quality management system, so design controls and compliance documentation are built into the work as it happens. Our medical device development services cover every phase.

Creating medical devices that are safe, usable and compliant is demanding from start to finish, and it follows a recognizable pattern. Programs that choose their regulatory pathway early, that study real clinical use before locking a form factor, and that build traceability as they go rather than afterwards, reach the market on schedules they can actually defend.

Everything in this guide comes down to that: the expensive decisions in medical device development are made in the first two phases, long before anyone 3D prints the first part.

Get a free, 45-minute consultation with our industry-leading experts

Frequently Asked Questions About Medical Device Development

At CLEIO, the five phases are Immerse, Define, Elaborate, Adapt and Launch. Immerse builds an understanding of the clinical need, the healthcare professionals and patients who will use the device, and the use environment, and checks early feasibility. Define turns those findings into design inputs and a regulatory strategy. Elaborate covers design, engineering and prototyping, Adapt verifies and validates the device, and Launch transfers it to manufacturing and the market.
Verification confirms you built the device according to its specifications. Validation confirms you built the right device for its intended use. Verification is mostly bench and lab testing against design inputs, while validation includes human factors validation testing and, when required, clinical data.
It depends mainly on device class. A Class II device on the 510(k) pathway typically takes 12 to 24 months, and a Class III device on the PMA pathway can take 3 to 5 years, largely because of clinical trials. Class I devices are usually the fastest, since most are exempt from premarket submission.
ISO 13485 establishes a quality management system framework specifically designed for medical device product development organizations. It ensures traceability, risk management, and documentation practices meet international regulatory expectations across markets including the FDA, Health Canada, and EU MDR jurisdictions.

A 510(k) shows that your device is substantially equivalent to a legally marketed predicate device. It covers most Class II devices and leads to FDA clearance. A PMA requires valid scientific evidence of safety and effectiveness, generally from clinical trials, applies to Class III devices and leads to FDA approval. We compare both, along with De Novo, in our guide to the medical device regulatory pathway.

In our experience, the biggest challenges come down to timing: regulatory requirements confirmed too late, usability problems found during summative evaluation, and documentation rebuilt after the fact. All three become far easier to manage when the regulatory strategy, user research and risk analysis happen in the first two phases.

Subscribe to get our insights delivered to your email inbox